An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

Nearly 55,000 Nevadans are currently living with Alzheimer’s, but as many as half of them have not been formally diagnosed. The FDA approved the first blood-based biomarker test for use by primary ...

The Wisconsin Chapter of the Alzheimer's Association wants "truth-in-advertising" legislation for facilities that advertise ...

HOUSTON – For Texans star defensive end Will Anderson Jr., his meeting with military service veterans at Camp Hope inspired ...

To help prevent dementia and Alzheimer's disease, people should take a brisk walk each day, limit their TV time and do a crossword puzzle instead.

The past two decades have seen major advances in Alzheimer's disease research and clinical care, catalysed by the development of CSF and blood biomarkers and PET imaging that reliably detect amyloid β ...

Q: My doctor just told me that I’m now considered obese. A week ago, I wasn’t — and I haven’t gained any weight. What’s going ...

The Wisconsin Chapter of the Alzheimer's Association wants "truth-in-advertising" legislation for facilities that advertise ...

Alzheimer's disease impacts millions of Americans and this weekend, the community has a chance to take action, raise awareness and support local families. Senate to vote Friday on pathway to end ...

An experimental pill could slow memory loss and brain shrinkage in some Alzheimer’s patients, new research suggests. The pill, called ALZ-801 (valiltramiprosate), was shown to be effective in people ...

Breast cancer survivors had a slightly lower risk of Alzheimer's dementia than cancer-free controls in Korea. Radiation therapy, but not other treatments, was tied to reduced Alzheimer's dementia risk ...